InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (11 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Koppikar Utpal, Chief Financial Officer. Director active across 3 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 13 filings have been published. Breakdown: 1 buy · 11 sells. Total volume traded: €407k. History available since 18 May 2021. The latest transaction was filed on 2 March 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Koppikar Utpal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
6,871 shares@ US$3.6275.6% of flowCommon StockSEC:0001567619-23-004538:0
5,667 shares@ US$5.60100.0% of flowCommon StockSEC:0001662579-23-000027:0
Canonical exit: 9 May 2023 (T+90)
2,485 shares@ US$5.463.0% of flowCommon StockSEC:0001567619-23-002174:0
5,172 shares@ US$4.495.3% of flowCommon StockSEC:0001140361-22-042378:0
5,940 shares@ US$5.0357.0% of flowCommon StockSEC:0001140361-22-030297:0
5,853 shares@ US$5.630.038% mcap9.3% of flowCommon StockSEC:0001567619-22-012667:0
4,616 shares@ US$5.3160.029% mcap7.0% of flowCommon StockSEC:0001140361-22-019988:0
61,235 shares0Common StockSEC:0001140361-22-007767:0
2,496 shares@ US$14.46158.4% of flowCommon StockSEC:0001567619-22-003052:0
3,655 shares@ US$17.116914.6% of flowCommon StockSEC:0001567619-21-020778:0
3,579 shares@ US$12.53210.2% of flowCommon StockSEC:0001567619-21-016148:0
5,820 shares@ US$14.0617.8% of flowCommon StockSEC:0001567619-21-011898:0
3,616 shares@ US$14.5511.4% of flowCommon StockSEC:0001209191-21-034424:0
13 of 13 declarations
About Koppikar Utpal
Koppikar Utpal is Chief Financial Officer and a Director at Atara Biotherapeutics, Inc. and C4 Therapeutics, Inc. He has 13 filings in total, and across the 13 recent filings observed between 2021-05-20 and 2023-03-06, the stated cumulative amounts are EUR 29577 in purchases and EUR 376957 in sales, with the dominant transaction nature shown as sell.
